Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Genomic dynamics and macrolide resistance in Bordetella pertussis: implications for surveillance and rapid visual detection
Yilu Zhuang; Shuangshuang Li; Danni Bao; Xiaoyang Jin; Fangbin Xiao; Qing He; Huiqiong Jia; Fang Shen; Tian Jiang; Xinyou Xie; Jun Zhang; Patrick Butaye; João Pedro Rueda Furlan; Fang He; Yingying Zhang; Xingyu Lin; Zhi RuanShow moreShow less
Department of Clinical Laboratory, Key Laboratory of Precision Medicine in Diagnosis and Monitoring Research of Zhejiang Province, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China; Department of Clinical Laboratory, Sanmen People’s Hospital, Sanmen Bay Branch of The First Affiliated Hospital, Zhejiang University School of Medicine, Taizhou, China; College of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou, China; Department of Laboratory Medicine, Zhejiang Key Laboratory of Clinical In Vitro Diagnostic Techniques, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Department of Clinical Laboratory, Shaoxing Second Hospital, Shaoxing, China; Department of Clinical Laboratory, Affiliated Wenling Hospital, Wenzhou Medical University, Wenling, China; Department of Infectious Diseases and Public Health, Jockey Club College of Veterinary, City University of Hong Kong, Hong Kong Special Administrative Region of China; Department of Pathobiology, Pharmacology and Zoological Medicine, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium; Department of Pharmaceutical Sciences, Health Sciences Center, Federal University of Paraíba, João Pessoa, Paraíba, Brazil; Laboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, ChinaShow moreShow less
SRSF1-DLAT axis drives mitochondrial fusion to confer therapy resistance in diabetes-associated pancreatic ductal adenocarcinoma
Zuwei Wang; Yiting Chen; Jinpeng Lu; Haoxiang Zhang; Yu Pan; Shuncang Zhu; Hongyi Lin; Ge Li; Yinhao Chen; Chengyu Liao; Long Huang; Yifeng Tian; Shi ChenShow moreShow less
Department of Hepatobiliary Pancreatic Surgery, Fuzhou University Affiliated Provincial Hospital, Fuzhou, 350001, China; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China; Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, China; Department of Hepatobiliary Surgery, Fujian Institute of Hepatobiliary Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, China; College of Biological Science and Engineering, Fuzhou University, Fuzhou, Fujian, 350108, China; Fujian Provincial Institute of Clinical Geriatrics, Fuzhou, 350001, ChinaShow moreShow less
Nationwide dalbavancin surveillance identifies sagB-associated cell-wall adaptation linked to reduced lipoglycopeptide susceptibility in CC5 Staphylococcus aureus
Yueqin Hong; Hemu Zhuang; Haiping Wang; Yan Guo; Keren Shi; Yiyi Chen; Feiteng Zhu; Xin Zhang; Fupin Hu; Lu Sun; Yunsong Yu; Yan ChenShow moreShow less
Department of Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China; Department of Respiratory and Critical Medicine, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China; Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China; Department of Pathology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China; First Department of Infectious Diseases, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, ChinaShow moreShow less
Nucleolar METTL16 drives ccRCC tumorigenesis and pazopanib resistance via translational activation of JAG1/Notch signaling pathway
Zixuan Gong; Keqin Dong; Wenjin Chen; Yifan Liu; Muchen Li; Wenjie Ma; Hongfeng Zheng; Hangbiao Zhang; Sichen Di; Wang Zhou; Xiuwu Pan; Xingang CuiShow moreShow less
Department of Urology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China; Department of Urology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200000, ChinaShow moreShow less
Nucleolin shields PTBP1 from autophagic degradation to sustain gemcitabine resistance in bladder cancer
Yunyi Liu; Yatao Wu; Juan Li; Ting Liu; Changyue Yuan; Yuxi Xu; Hailong Ou; Shu Zhou; Dan Qi; Huan Liao; Mingyang He; Bi Shi; Jason H. Huang; Erxi Wu; Xiaoxiao HuShow moreShow less
State Key Laboratory of Chemo/Biosensing and Chemometrics, Hunan Research Center of the Basic Discipline for Cell Signaling, Molecular Science and Biomedicine Laboratory and Aptamer Engineering Center of Hunan Province, College of Biology, Hunan University, Changsha, Hunan, 410082, China; Xinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi, 830017, China; Shenzhen Research Institute, Hunan University, Shenzhen, Guangdong, 518000, China; Research Institute of Hunan University in Chongqing, Chongqing, 401120, China; Innovation Institute of Industrial Design and Machine Intelligence, Quanzhou-Hunan University, 362006, China; Department of Neurosurgery and Neuroscience Institute, Baylor Scott & White Health, Temple, TX, 76508, USA; Department of Neurosurgery, Baylor College of Medicine, Temple, TX, 76508, USA; Baylor Research Institute, Baylor Scott & White Health, Temple, TX, 76508, USAShow moreShow less
Piperidine-derived resensitizers revive aminoglycoside capacity against persister cells of Pseudomonas aeruginosa in vivo
Yeseul Kim; Minju Kim; Haneun Lee; Areum Park; Su Yong Shim; Yura Lee; Kyungjin Lee; Soohyun Lee; Do Young Jin; Jun-Seob Kim; Dongeun Yong; Won-Gon Kim; Choong-Min Ryu; Hyuk Lee; Hwi Won Seo; Jaesung Kwak; Dajeong KimShow moreShow less
Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Republic of Korea; Department of Functional Genomics, KRIBB School, University of Science and Technology (UST), Daejeon 34113, Republic of Korea; Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon 34114, Republic of Korea; Department of Chemistry, Yonsei University, Seoul 03722, Republic of Korea; Department of Chemistry, Hanyang University, Seoul 04763, Republic of Korea; Division of Medicinal Chemistry and Pharmacology, KRICT School, UST, Daejeon 34113, Republic of Korea; Department of Biosystems and Bioengineering, KRIBB School, UST, Daejeon 34113, Republic of Korea; Department of Nano-Bioengineering, Incheon University, Incheon 22012, Republic of Korea; Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul 03722, Republic of KoreaShow moreShow less
FAQ
How long does DRUG RESISTANCE UPDATES take to review a manuscript?
As of 2026-11-19, CrushSCI has 15 complete review records for DRUG RESISTANCE UPDATES. The fastest paper went from submission to acceptance in 49 days (Nucleolar METTL16 drives ccRCC tumorigenesis and pazopanib resistance via translational activation of JAG1/Notch signaling pathway, received 2026-07-28, accepted 2026-09-15); the slowest took 223 days. The average is 119.7 days and the median is 113 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
